Caribou Biosciences, Inc.
Insider CIK 1619856 · NTLA 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| NTLA Intellia Therapeutics, Inc | S Sale | 2018-01-29 | 2018-01-30 | 550,645 | $26.78 | $14.75M | 3,994,355 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | S Sale | 2017-09-13 | 2017-09-13 | 1,048,846 | — | $0 | 4,545,000 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 8,110,599 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion deriv | 2016-05-11 | 2016-05-11 | 270,352 | — | $0 | 0 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 5,244,234 | — | $0 | 5,593,846 | SEC↗ |
| NTLA Intellia Therapeutics, Inc | C Conversion | 2016-05-11 | 2016-05-11 | 174,806 | — | $0 | 349,612 | SEC↗ |